Early Changes in Bone Mineral Density Above a Combined Anteroposterior L4-S1 Lumbar Spinal Fusion

Spine ◽  
1995 ◽  
Vol 20 (15) ◽  
pp. 1674-1678 ◽  
Author(s):  
G. Mitchell Bogdanffy ◽  
Donna D. Ohnmeiss ◽  
Richard D. Guyer
2004 ◽  
Vol 17 (01) ◽  
pp. 41-47
Author(s):  
S. A. Martinez ◽  
L. V. Smith ◽  
W. J. Carroll ◽  
J. A. Zimmermann ◽  
M. S. Shih ◽  
...  

SummaryIn human medicine, lumbar spinal fusion procedures for chronic degenerative conditions have significant failure rates leading to the formation of pseudoarthroses. Adjunct procedures including the use of electrical stimulation devices have been developed in animal models, and utilized in human clinical cases, in an attempt to reduce the incidence of nonunion. A randomized, controlled study was performed to compare the effects of two surface interferential stimulation devices (SIS) on a rabbit lumbar spinal fusion model. Twenty-five rabbits underwent bilateral intertransverse process arthrodesis at the L2-L3 disc space. The rabbits were divided into five groups: one control group receiving sham stimulation, and four treatment groups receiving interferential stimulation from one of two devices (RS4i at 13.3 mA, RS4i at 15.8 mA, RS4v at 11.6 mA, and RS4v at 14.8 mA). Dual energy X-ray absorptiometry analyses (DXA) were performed and at 2 week intervals to evaluate fusion site bone mineral density. All rabbits were euthanitized at eight weeks and fusion sites were evaluated for biomechanical strength and histomorphometric properties. There was not any difference in bone mineral density between the groups during the eight week test period. The uniaxial tension tests evaluating maximum load to failure, stiffness, and energy absorbed also resulted in no statistical differences between the groups. The RS4i device at 15.8 mA yielded an increased amount of lamellar bone compared to the control group (p = 0.02). The RS4v device at 11.6 mA resulted in less total bone than the control group (p = 0.04).


2019 ◽  
Vol 19 (2) ◽  
pp. 238-245 ◽  
Author(s):  
Stephan N. Salzmann ◽  
Courtney Ortiz Miller ◽  
John A. Carrino ◽  
Jingyan Yang ◽  
Jennifer Shue ◽  
...  

Bone ◽  
2011 ◽  
Vol 48 ◽  
pp. S201 ◽  
Author(s):  
S.A. Polyzos ◽  
A.D. Anastasilakis ◽  
C. Bratengeier ◽  
W. Woloszczuk ◽  
A. Papatheodorou ◽  
...  

2009 ◽  
Vol 3 (1) ◽  
pp. 1 ◽  
Author(s):  
Byung-Hak Kim ◽  
Heun-Guyn Jung ◽  
Kyung-Ho Park ◽  
Dae-Hee Kim ◽  
Yong-Soo Choi

2021 ◽  
Author(s):  
Hyung-Youl Park ◽  
Ji-Yoon Ha ◽  
Ki-Won Kim ◽  
In-Hwa Baek ◽  
Soo-Bin Park ◽  
...  

Abstract Background: Lumbar spinal stenosis (LSS) can cause various neurological symptoms and reduce the daily activity of patients. Many studies have shown that free physical activities and exercise can improve bone mineral density (BMD) in patients with osteoporosis. However, the effect of LSS on BMD has not been reported. The purpose of this study was to investigate the effects of LSS on BMD in patients treated with ibandronate for newly diagnosed osteoporosis.Methods: Group 1 included 83 patients with osteoporosis alone, and group 2 included 76 patients with both osteoporosis and symptomatic LSS. We confirmed four BMD values presented as T-score at initial, and 1-, 2-, and 3-year follow-ups. Mean BMD and annual changes of BMD for three years were compared between the two groups. Correlations between initial BMD and total change of BMD were also analyzed in both groups.Results: Mean annual BMDs were significantly higher in group 1 compared than in group 2 (-3.39 vs. -3.58 at 1-year; -3.27 vs. -3.49 at 2-year; -3.13 vs. -3.45 at 3-year; all p < 0.05). Annual change of BMD at 1-year follow-up (0.32 vs. 0.21, p = 0.036) and total change of BMD for three years (0.57 vs. 0.35, p = 0.002) were significantly higher in group 1. Group 1 had a strong negative correlation (r = -0.511, P = 0.000) between initial BMD and total change of BMD, whereas group 2 showed a weak negative correlation (r = -0.247, p = 0.032).Conclusions: Symptomatic LSS may interfere with BMD improvement in the treatment of osteoporosis with ibandronate. Active treatment for LSS with more potent treatment for osteoporosis should be taken to increase BMD for patients with osteoporosis and LSS.


2020 ◽  
Vol 20 (9) ◽  
pp. S170
Author(s):  
Astrid Gimbel ◽  
Mikkel Andersen ◽  
Annette Bennedsgaard Jespersen ◽  
Anne Pernille Hermann ◽  
Leah Y. Carreon

Neonatology ◽  
1993 ◽  
Vol 64 (2-3) ◽  
pp. 96-103 ◽  
Author(s):  
Hirokazu Tsukahara ◽  
Masakatsu Sudo ◽  
Minoru Umezaki ◽  
Yasushi Fujii ◽  
Masanori Kuriyama ◽  
...  

2018 ◽  
Vol 6 (2) ◽  
pp. 170-176 ◽  
Author(s):  
Masayuki Ohashi ◽  
Toru Hirano ◽  
Kei Watanabe ◽  
Keiichi Katsumi ◽  
Hirokazu Shoji ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document